Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during ...

Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the completion of its $550 million manufacturing plant in the town of Holly Springs ...

On January 23, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a ...

Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart ...

The Phase III CodeBreaK 300 study returned disappointing overall survival data for Lumakras plus Vectibix in metastatic ...

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company ...

Amgen,bringing better ... professor of theology at Georgetown University and author of theforthcoming book, 'Science and Religion: From Conflict toConversation.' The topic before this house ...

A skilled work force help attract Amgen to North Carolina, said state Commerce Secretary Machelle Baker Sanders. “I spent much of my career in the life science industry, and helping North ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Amgen (AMGN) closed the most recent trading day at $260.64, moving +0.52% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.43%. Elsewhere, the Dow lost 0.07% ...